DTI MRI Scans Reveal Brain Differences in Six-Month-Old Autistic Infants
By MedImaging International staff writers Posted on 28 Feb 2012 |

Image: A visualization of white matter pathways in the brains of infants at-risk for autism. Warmer colors represent levels of white matter organization and development (Photo courtesy of Jason Wolff).
New findings suggest that autism does not appear suddenly in young children, but instead develops over time during infancy. This discovery is significant because it brings scientists one-step closer to developing a biomarker to assist with very early diagnoses for autism spectrum disorders.
A new study from the Infant Brain Imaging Network found significant differences in brain development starting at age six months in high-risk infants who later develop autism, compared to high-risk infants who did not develop autism. “It’s a tremendously exciting finding,” said Sarah Paterson, PhD, director of the Infant neuroimaging lab at the Center for Autism Research at The Children’s Hospital of Philadelphia (CHOP; PA, USA). “We found that the brains of the children who developed autism were markedly different even prior to the onset of behavioral symptoms of autism. Thus, our findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk. This would enable specialists to diagnose autism much earlier than what is currently possible through behavioral observations.”
The study also suggests that autism does not appear abruptly in young children but instead develops over time during infancy, noted the researchers. Intensive early intervention has been shown to improve outcomes in children with developmental delays and autism. “This research raises the possibility that we might be able to intervene even before a child is six months old, to blunt, or prevent the development of some autism symptoms,” said Dr. Paterson.
The study was published February 17, 2012, in the American Journal of Psychiatry. These findings are the latest from the ongoing Infant Brain Imaging Study (IBIS), which is led at CHOP by Dr. Paterson and Robert Schultz, PhD, who are coauthors on this study.
Participants in the study were 92 infants believed to be at high risk for ASD, because they all have older siblings with autism. Each infant had diffusion tensor imaging (DTI)--a type of magnetic resonance imaging (MRI)--at six months and behavioral assessments at 24 months. Most of the children also had additional brain imaging scans at either or both 12 and 24 months.
At 24 months, 28 infants (30%) met criteria for ASDs while 64 infants (70%) did not. The two groups differed in white matter fiber tract development--pathways that connect brain regions--as measured by fractional anisotropy (FA). FA measures white matter organization and development, based on the movement of water molecules through brain tissue.
This study examined 15 separate fiber tracts, and found considerable differences in FA growth trajectories in 12 of the 15 tracts between infants who did develop autism versus infants who did not. Infants who later developed autism had elevated FA at six months but then experienced slower development over time. By 24 months of age, infants with autism had lower FA values than infants without autism did.
The findings come on the heels of a recent study from London, UK, which found that infants at high risk for autism who were later diagnosed with the condition showed different brain responses from low-risk babies, or from high-risk babies that did not develop autism when shown images of faces looking at or away from the baby. Dr. Paterson reported that the two findings support one another and are promising evidence that scientists are on the right path towards finding markers for identifying autism much earlier than is currently possible.
In addition to the Center for Autism Research at CHOP, other institutions that took part in the study include the University of North Carolina (Chapel Hill, USA), University of Utah (Salt Lake City, USA), Washington University in St. Louis (MO, USA), University of Washington (Seattle, USA), McGill University (Montreal, Canada), and the University of Alberta (Edmonton, Canada).
The Center for Autism Research (CAR) is a collaborative effort between several dozen scientists across multiple departments at the Children’s Hospital of Philadelphia. CAR’s goals are to identify the causes of autism spectrum disorders (ASD) and to use that knowledge to develop more effective treatments. CAR conducts research studies for infants at risk for being diagnosed with ASD (due to having a sibling already diagnosed) as well as toddlers, school-aged children, and adults on the autism spectrum.
Related Links:
Center for Autism Research at The Children’s Hospital of Philadelphia
A new study from the Infant Brain Imaging Network found significant differences in brain development starting at age six months in high-risk infants who later develop autism, compared to high-risk infants who did not develop autism. “It’s a tremendously exciting finding,” said Sarah Paterson, PhD, director of the Infant neuroimaging lab at the Center for Autism Research at The Children’s Hospital of Philadelphia (CHOP; PA, USA). “We found that the brains of the children who developed autism were markedly different even prior to the onset of behavioral symptoms of autism. Thus, our findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk. This would enable specialists to diagnose autism much earlier than what is currently possible through behavioral observations.”
The study also suggests that autism does not appear abruptly in young children but instead develops over time during infancy, noted the researchers. Intensive early intervention has been shown to improve outcomes in children with developmental delays and autism. “This research raises the possibility that we might be able to intervene even before a child is six months old, to blunt, or prevent the development of some autism symptoms,” said Dr. Paterson.
The study was published February 17, 2012, in the American Journal of Psychiatry. These findings are the latest from the ongoing Infant Brain Imaging Study (IBIS), which is led at CHOP by Dr. Paterson and Robert Schultz, PhD, who are coauthors on this study.
Participants in the study were 92 infants believed to be at high risk for ASD, because they all have older siblings with autism. Each infant had diffusion tensor imaging (DTI)--a type of magnetic resonance imaging (MRI)--at six months and behavioral assessments at 24 months. Most of the children also had additional brain imaging scans at either or both 12 and 24 months.
At 24 months, 28 infants (30%) met criteria for ASDs while 64 infants (70%) did not. The two groups differed in white matter fiber tract development--pathways that connect brain regions--as measured by fractional anisotropy (FA). FA measures white matter organization and development, based on the movement of water molecules through brain tissue.
This study examined 15 separate fiber tracts, and found considerable differences in FA growth trajectories in 12 of the 15 tracts between infants who did develop autism versus infants who did not. Infants who later developed autism had elevated FA at six months but then experienced slower development over time. By 24 months of age, infants with autism had lower FA values than infants without autism did.
The findings come on the heels of a recent study from London, UK, which found that infants at high risk for autism who were later diagnosed with the condition showed different brain responses from low-risk babies, or from high-risk babies that did not develop autism when shown images of faces looking at or away from the baby. Dr. Paterson reported that the two findings support one another and are promising evidence that scientists are on the right path towards finding markers for identifying autism much earlier than is currently possible.
In addition to the Center for Autism Research at CHOP, other institutions that took part in the study include the University of North Carolina (Chapel Hill, USA), University of Utah (Salt Lake City, USA), Washington University in St. Louis (MO, USA), University of Washington (Seattle, USA), McGill University (Montreal, Canada), and the University of Alberta (Edmonton, Canada).
The Center for Autism Research (CAR) is a collaborative effort between several dozen scientists across multiple departments at the Children’s Hospital of Philadelphia. CAR’s goals are to identify the causes of autism spectrum disorders (ASD) and to use that knowledge to develop more effective treatments. CAR conducts research studies for infants at risk for being diagnosed with ASD (due to having a sibling already diagnosed) as well as toddlers, school-aged children, and adults on the autism spectrum.
Related Links:
Center for Autism Research at The Children’s Hospital of Philadelphia
Latest MRI News
- AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
- AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreNuclear Medicine
view channel
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more